Culliney Katherine A T, Parry Graham K, Brown Julie, Crowther Caroline A
Obstetrics and Gynaecology Department, Taranaki Base Hospital, David Street, Westown, New Plymouth, New Zealand, 4310.
Cochrane Database Syst Rev. 2016 Apr 5;4(4):CD011739. doi: 10.1002/14651858.CD011739.pub2.
Policies and protocols vary widely for fetal surveillance in a pregnancy where the fetus is suspected to be large-for-gestational-age (LGA). All ultimately culminate in decisions about the mode and timing of birth. LGA is known to be associated with increased risks to both the mother and baby. Interventions based on surveillance regimen findings may be associated with risks to the mother and baby.
To assess the effectiveness or efficacy of different antenatal surveillance methods for the suspected LGA fetus on important health outcomes for the mother and baby.
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 August 2015), ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) (21 August 2015).
Published and unpublished randomised, quasi-randomised and cluster-randomised trials comparing the effects of described antenatal fetal surveillance regimens for women with suspected LGA infants.
We identified no studies that met the inclusion criteria for this review.
There are no included trials.
AUTHORS' CONCLUSIONS: We found no randomised controlled trials that assessed the effect of antenatal fetal surveillance regimens of a suspected LGA fetus on important health outcomes for the mother and baby.There has been a rise in the prevalence of LGA babies over the past few decades in many countries. Research is therefore required on regimens of antenatal surveillance of suspected LGA infants, in order to guide practice and improve the health outcomes for the mother and infant. In particular, randomised control trials to investigate whether serial antenatal clinic and ultrasound assessments of suspected LGA infants (including liquor volume and markers of fetal adiposity) would be useful, to assess whether surveillance methods improve health outcomes. In addition, as there are concerns that identifying suspected LGA fetuses may lead to unnecessary maternal anxiety, investigations and interventions, any such trial would need to assess the risks as well as benefits of regimens of fetal surveillance for suspected LGA fetuses.
对于疑似胎儿大于孕周(LGA)的妊娠,胎儿监测的政策和方案差异很大。所有这些最终都归结为关于分娩方式和时机的决策。已知LGA与母婴风险增加有关。基于监测方案结果的干预措施可能会给母婴带来风险。
评估针对疑似LGA胎儿的不同产前监测方法对母婴重要健康结局的有效性或疗效。
我们检索了Cochrane妊娠与分娩组试验注册库(2015年8月30日)、ClinicalTrials.gov和世界卫生组织国际临床试验注册平台(ICTRP)(2015年8月21日)。
比较所述产前胎儿监测方案对疑似LGA婴儿的女性的影响的已发表和未发表的随机、半随机和整群随机试验。
我们未找到符合本综述纳入标准的研究。
没有纳入试验。
我们未找到评估疑似LGA胎儿的产前胎儿监测方案对母婴重要健康结局影响的随机对照试验。在过去几十年中,许多国家LGA婴儿的患病率有所上升。因此,需要对疑似LGA婴儿的产前监测方案进行研究,以指导实践并改善母婴健康结局。特别是进行随机对照试验,以调查对疑似LGA婴儿进行系列产前门诊和超声评估(包括羊水量和胎儿肥胖标志物)是否有用,以评估监测方法是否能改善健康结局。此外,由于担心识别疑似LGA胎儿可能导致不必要的母亲焦虑、检查和干预,任何此类试验都需要评估疑似LGA胎儿监测方案的风险和益处。